Cronos Group Inc (CRON)
2.035
-0.04
(-1.69%)
USD |
NASDAQ |
Nov 15, 15:10
Cronos Group Total Liabilities (Quarterly): 35.26M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 35.26M |
| March 31, 2024 | 35.76M |
| December 31, 2023 | 43.96M |
| September 30, 2023 | 33.35M |
| June 30, 2023 | 31.67M |
| March 31, 2023 | 33.18M |
| December 31, 2022 | 72.04M |
| September 30, 2022 | 46.23M |
| June 30, 2022 | 47.25M |
| March 31, 2022 | 49.63M |
| December 31, 2021 | 63.46M |
| September 30, 2021 | 78.77M |
| June 30, 2021 | 208.70M |
| March 31, 2021 | 313.00M |
| December 31, 2020 | 217.51M |
| September 30, 2020 | 154.44M |
| June 30, 2020 | 247.24M |
| March 31, 2020 | 212.66M |
| December 31, 2019 | 341.41M |
| September 30, 2019 | 464.26M |
| Date | Value |
|---|---|
| June 30, 2019 | 1.099B |
| March 31, 2019 | 1.294B |
| December 31, 2018 | 34.92M |
| September 30, 2018 | 9.431M |
| June 30, 2018 | 6.209M |
| March 31, 2018 | 6.930M |
| December 31, 2017 | 11.66M |
| September 30, 2017 | 9.588M |
| June 30, 2017 | 3.161M |
| March 31, 2017 | 5.997M |
| December 31, 2016 | 6.862M |
| September 30, 2016 | 6.877M |
| June 30, 2016 | 0.3187M |
| March 31, 2016 | 2.050M |
| December 31, 2015 | 2.178M |
| September 30, 2015 | 1.690M |
| June 30, 2015 | 1.596M |
| March 31, 2015 | 0.7145M |
| September 30, 2014 | 0.0393M |
| June 30, 2014 | 0.0365M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
31.67M
Minimum
Jun 2023
341.41M
Maximum
Dec 2019
119.24M
Average
63.46M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Tilray Brands Inc | 778.45M |
| Aurinia Pharmaceuticals Inc | 161.36M |
| Edesa Biotech Inc | 2.361M |
| Lexaria Bioscience Corp | 0.2714M |
| Xenon Pharmaceuticals Inc | 39.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.091B |
| Shareholders Equity (Quarterly) | 1.059B |
| Current Ratio | 28.29 |